LivaNova PLC (LIVN)

Nasdaq: LIVN · Electromedical & Electrotherapeutic Apparatus · London, GB · filing with the SEC since 2015

Grade5.3

◀ Past 4.7● Present 5.8▶ Future 5.3

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Feb 25, 2026	Feb 25, 2025	Feb 29, 2024	Feb 27, 2023	Mar 1, 2022	Mar 1, 2021	Mar 2, 2020	Mar 18, 2019	Feb 28, 2018	Mar 1, 2017
Revenue	1,388,053	1,253,437	1,153,545	1,021,805	1,035,365	934,241	1,084,170	1,106,961	1,012,277	964,858
Cost of revenue	448,183	399,953^r	397,725^r	314,577	329,371	339,478^r	360,365^r	361,321^r	353,192^r	367,845^r
Gross profit	939,870	853,484^r	755,820^r	707,228	705,994	594,763	723,805	·	651,620	559,506^r
Research and development	185,764	182,514	193,817	155,805	183,414	152,902	146,849^r	145,948^r	109,516^r	82,078^r
Selling, general and administrative	548,813	508,876^r	502,699^r	469,243	471,904	446,561^r	528,466^r	464,967	380,100^r	355,164^r
Total operating expenses	·	·	·	·	·	·	·	·	555,950	528,063^r
Operating income	199,390	129,051	-68,498	-76,752	-784	-273,899^r	-171,554^r	-248,072	96,487^r	33,448^r
Interest expense	49,286	63,070	58,853	48,250	50,151	40,837	15,091	9,825	7,797	10,616
Interest and investment income	18,982	30,075	22,012	4,697	435	131	803	847	1,318	1,698
Share of profit of equity-method investments	-51	-18	-104	-53	-148	-264	0	-644	-16,719	-18,679^r
Other income (expense), net	664	1,096^r	609^r	691	·	·	·	·	·	·
Total non-operating income (expense)	-2,681	47,811	46,125	·	·	·	·	·	·	·
Income before income taxes	-220,781	88,310	-81,226	-75,142	-124,472	-348,022^r	-188,378^r	-247,447	121,138	25,666
Income tax expense	21,639	25,058	-98,876	11,051	11,198	-960^r	-30,374^r	-69,629	49,954	5,113^r
Income from continuing operations	·	·	·	-86,246	-135,818	-347,326^r	-158,004^r	-178,462	54,465	1,874
Income from discontinued operations	·	·	·	0	0	-1,493	365	-10,937	-79,554	-64,663
Net income	-242,471	63,234	17,546	-86,246	-135,818	-348,819^r	-157,639^r	-189,399	-25,089	-62,789
Earnings per share, basic	-4.45	1.17	0.33	-1.61	-2.68	-7.18^r	-3.21	-3.91	-0.52	-1.29
Earnings per share, diluted	-4.45	1.16	0.32	-1.61	-2.68	-7.18^r	-3.26^r	-3.91	-0.52	-1.28^r
Weighted average shares, basic	54,548	54,240	53,939	53,472	50,633	48,592	48,349	48,497	48,157	48,860^r
Weighted average shares, diluted	54,548	54,574	54,212	53,472	50,633	48,592	48,349	48,497	48,501	49,014^r

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:SalesRevenueNet

Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earned

us-gaap:InvestmentIncomeInterest
us-gaap:InvestmentIncomeNet

Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before tax

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations

Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton LIVN · research, not advice